SpinrazaActive Ingredient(s): Nusinersen
FDA Approved: * December 23, 2016
Pharm Company: * BIOGEN
Category: Neurological Disorders
Nusinersen, marketed as Spinraza, is a medication used in treating spinal muscular atrophy (SMA), a rare neuromuscular disorder. In December 2016, it became the first approved drug used in treating this disorder. Since the condition it treats is so rare, Nusinersen has so-called “orphan drug” designation in the United States and the European Union. Contents 1 Medical uses 2 Side effect... [wikipedia]* May have multiple approval dates, manufacturers, or labelers.